The Radiotherapeutics Moment: How Isotopes are Changing Cancer Treatment
BioSpace · BioSpace
Audio is streamed directly from the publisher (api.riverside.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode of Denatured, you'll listen to Dr. Marc Hedrick, President and CEO of Plus Therapeutics and Dr. Phil Kantoff, CEO & Co-founder of Convergent Therapeutics. They discuss breakthroughs like alpha-emitting isotopes, supply chain solutions and why radiotherapeutics is biotech's next big frontier.
Host
Jennifer C. Smith-Parker, Director of Insights, BioSpace
Guests
Marc Hedrick, President & CEO, Plus Therapeutics
Philip Kantoff, Co-founder & CEO, Convergent Therapeutics
Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.